Stock Analiz

Cellectis S.A. (CLLS) stock forecast and price target

Price $1.18 · data as of November 13, 2026

12-month price target

Average target$4.45
Upside / downside+277.1%
Analysts4
ConsensusBuy
Low $1.30Average $4.45High $8.00

Gold marker: average target · white marker: today’s price ($1.18)

Analyst ratings

Strong buy 0Buy 2Hold 2Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.25−104.9%$29M
Next fiscal year
ends December 31, 2027
$-0.55+56.0%$36M
Next quarter
ends December 31, 2026
$-0.22+8.3%$8M
Quarter after
ends March 31, 2027
$-0.19—$23M

Consensus of the analysts covering Cellectis, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Cellectis stock price target?

The average 12-month target from 4 analysts is $4.45, 277.1% above the current price of $1.18 Targets range from $1.30 to $8.00.

Is Cellectis a buy according to analysts?

The consensus rating is “Buy” (2 buy, 2 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Cellectis expected to earn?

Analysts expect EPS of $-1.25 for the fiscal year ending December 31, 2026 and $-0.55 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.